FIXED PROLONGED REGIME OF COMBINED ORAL CONTRACEPTIVES (COC) INTAKE IN SOLUTION OF CLASSIC CONTRACEPTION ISSUES (LITERATURE REVIEW)
https://doi.org/10.21518/2079-701X-2017-11-182-185
Abstract
Combined oral contraceptives (COC) – the most popular reversible method to prevent unwanted pregnancy used in the whole world. The popularity of COC remains unchanged since the moment of their appearance [1]. Thus, in the US COC are used by each 4 out of 5 women using combined hormonal contraceptives [2]. In Russia the whole diversity is available now: of various dosage forms of hormonal contraceptives (tablets, vaginal rings, patches, implants, intrauterine hormonal releasing systems), and of formulations (use of ethinyl estradiol and estrogens analogous to natural ones, use of progestogens of all types) and intake regimes as well (one-time and urgent, daily, monthly, for several years) that allows the doctor in cooperation with the female patient to conduct the informed choice of the most optimal method of contraception. But in Russia the situation that is extremely untypical for other countries remains. On the one hand, complete availability of hormonal contraceptives, on the other hand, the degree of their use and indication remains on the sufficiently low level.
About the Authors
V. N. Prilepskaya
Kulakov Scientific Center of Obstetrics, Gynecology and Perinatology
Russian Federation
Russian Federation
MD, Prof.
Moscow
E. A. Minaeva
Kulakov Scientific Center of Obstetrics, Gynecology and Perinatology
Russian Federation
Russian Federation
Moscow
References
1. Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. Natl Health Stat Rep, 2012, (60): 1–25.
2. Daniels K, Mosher WD. Contraceptive methods women have ever used: United States, 19822010. Natl Health Stat Rep, 2013, (62): 1–15.
3. Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet, 2000 Mar 11, 355(9207): 922-4.
4. Pincus G, Rock J, Garcia CR, et al. Fertility control with oral medication. Am J Obstet Gynecol, 1958, 75: 1333-1346.
5. Loudon NB, Foxwell M, Potts DM, et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tricycle pill regimen. Br Med J, 1977, 2: 487-490.
6. Kroll R, Reape KZ, Margolis M. The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol. Contraception, 2010, 81(1): 41–48.
7. Armstrong C. ACOG Guidelines on Noncontraceptive Uses of Hormonal Contraceptives. Obstet Gynecol, 2014, 115: 06-18.
8. Benson LS, Micks EA. Why Stop Now? Extended and Continuous Regimens of Combined Hormonal Contraceptive Methods. Obstet Gynecol Clin North Am, 2015 Dec, 42(4): 669-81.
9. Trussell J. Contraceptive failure in the United States. Contraception, 2011 May, 83(5): 397-404. doi: 10.1016/j.contraception.2011.01.021. Epub 2011 Mar 12.
10. Reape KZ, DiLiberti CE, Hendy CH, Volpe EJ. Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive. Contraception, 2008 Jan, 77(1): 34-9.
11. Kaunitz AM, Portman DJ, Hait H, Reape KZ. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive. Contraception, 2009 May, 79(5): 350-5. doi: 10.1016/j.contraception.2008.11.011. Epub 2009 Jan 17.
12. Krishnan S, Kiley J. The lowest-dose, extendedcycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 mug/levonorgestrel 100 mug 1 ethinyl estradiol 10 mug. Int J Womens Health, 2010, 2: 235–9.
13. По данным http: //grls.rosminzdrav.ru/ от 20.05.2017.
14. Инструкция по применению лекарственного препарата для медицинского применения МОДЭЛЛЬ® ЛИБЕРА.
15. Lidegaard O, Nielsen LH, Skovlund CW, et al. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ, 2012, 344: e2990.
16. Wiegratz I, Kuhl H. Metabolic and clinical effects of progestogens. Eur J Contracept Reprod Health Care, 2006 Sep, 11(3): 153-61.
17. Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women. In EMEA/CPMP/ EWP/519/98 Rev 1, 2005.
Review
For citations:
Prilepskaya VN, Minaeva EA. FIXED PROLONGED REGIME OF COMBINED ORAL CONTRACEPTIVES (COC) INTAKE IN SOLUTION OF CLASSIC CONTRACEPTION ISSUES (LITERATURE REVIEW). Meditsinskiy sovet = Medical Council. 2017;(11):182-185. (In Russ.) https://doi.org/10.21518/2079-701X-2017-11-182-185
Views:
978
Email this article 